Skip to main content

GE HealthCare Technologies Inc

For the period ended Mar 31, 2024. Filed Apr 30, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed Apr 30, 2024

GEHC$83.65-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Non-GAAP Financial Measures

The non-GAAP financial measures presented in this Quarterly Report on Form 10-Q are supplemental measures of our performance and our liquidity that we believe help investors understand our financial condition, cash flows, and operating results, and assess our future prospects. We believe that presenting these non-GAAP financial measures, in addition to the corresponding U.S. GAAP financial measures, are important supplemental measures that exclude non-cash or other items that may not be indicative of or related to our core operating results and the overall health of our company. We believe that these non-GAAP financial measures provide investors greater transparency to the information used by management for its operational decision-making and allow investors to see our results “through the eyes of management.” We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. When read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as one basis for making financial, operational, and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry.

The non-GAAP financial measures we report include:

Organic revenue and Organic revenue growth rate

We believe that Organic revenue and Organic revenue growth rate, by excluding the effect of acquisitions, dispositions, and foreign currency rate fluctuations, provide management and investors with additional understanding and visibility into the underlying revenue trends of our established, ongoing operations. Organic revenue and Organic revenue growth rate also provide greater insight regarding the overall demand for our products and services.

EBIT, Adjusted EBIT, and Adjusted EBIT margin

We believe Adjusted EBIT and Adjusted EBIT margin provide management and investors with additional understanding of our business by highlighting the results from ongoing operations and the underlying profitability factors. EBIT represents our earnings excluding interest expense, interest income, earnings (loss) attributable to non-controlling interests, non-operating benefit (income) costs, and tax expense. Adjusted EBIT additionally excludes non-recurring and/or non-cash items, which may have a material impact on our results. We may from time to time consider excluding other non-recurring items to enhance comparability between periods. We believe this provides additional insight into how our businesses are performing, on a normalized basis. However, Adjusted EBIT and Adjusted EBIT margin should not be construed as inferring that our future results will be unaffected by the items for which the measure adjusts.

Adjusted net income

We believe Adjusted net income provides investors with improved comparability of underlying operating results and a further understanding and additional transparency regarding how we evaluate our business. Adjusted net income also provides management and investors with additional perspective regarding the impact of certain significant items on our earnings. Adjusted net income excludes non-operating benefit (income) costs, certain tax expense adjustments, and non-recurring and/or non-cash items, which may have a material impact on our results. We may from time to time consider excluding other non-recurring items to enhance comparability between periods. However, Adjusted net income should not be construed as inferring that our future results will be unaffected by the items for which the measure adjusts.

Adjusted earnings per share

We believe Adjusted earnings per share provides investors with improved comparability of underlying operating results and a further understanding and additional transparency regarding how we evaluate our business. Adjusted earnings per share also provides management and investors with additional perspective regarding the impact of certain significant items on our per share earnings. Adjusted earnings per share excludes non-operating benefit (income) costs, certain tax expense adjustments, and non-recurring and/or non-cash items, which may have a material impact on our results. We may from time to time consider excluding other non-recurring items to enhance comparability between periods. However, Adjusted earnings per share should not be construed as inferring that our future results will be unaffected by the items for which the measure adjusts.

Adjusted tax expense and Adjusted effective tax rate

We believe that Adjusted tax expense and Adjusted effective tax rate provide investors with a better understanding of the normalized tax rate applicable to our business and provide more consistent comparability across periods. Adjusted tax expense excludes the income tax related to the pre-tax income adjustments included as part of Adjusted net income and certain income tax adjustments, such as adjustments to deferred tax assets or liabilities. We may from time to time consider excluding other non-recurring tax items to enhance comparability between periods. Adjusted effective tax rate is Adjusted tax expense divided by Income before income taxes less pre-tax income adjustments detailed above in Adjusted net income. However, Adjusted tax expense and Adjusted effective tax rate should not be construed as inferring that our future results will be unaffected by the items for which the measure adjusts.

Free cash flow

We believe that Free cash flow provides management and investors with an important measure of our ability to generate cash on a normalized basis. Free cash flow also provides insight into our flexibility to allocate capital, including reinvesting in the Company forfuture growth, paying down debt, paying dividends, and pursuing other opportunities that may enhance stockholder value. Free cash flow is Cash from (used for) operating activities including cash flows related to the additions and dispositions of property, plant, and equipment (“PP&E”) and internal-use software. Additionally, Free cash flow does not represent residual cash flows available for discretionary expenditures, due to the fact that the measures do not deduct the payments required for debt repayments.

Non-GAAP Reconciliations

Management recognizes that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business. The reconciliations of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure are provided below.

Organic Revenue*For the three months ended March 31
20242023% change
Imaging revenues$2,466$2,496(1)%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange(27)—
Imaging Organic revenue*$2,493$2,496—%
Ultrasound revenues$824$859(4)%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange(5)—
Ultrasound Organic revenue*$829$859(4)%
PCS revenues$747$781(4)%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange(1)—
PCS Organic revenue*$748$781(4)%
PDx revenues$599$5587%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange(1)—
PDx Organic revenue*$600$5588%
Other revenues$15$1312%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange——
Other Organic revenue*$14$1311%
Total revenues$4,650$4,707(1)%
Less: Acquisitions(1)——
Less: Dispositions(2)——
Less: Foreign currency exchange(34)—
Organic revenue*$4,684$4,707—%
(1)Represents revenues attributable to acquisitions from the date the Company completed the transaction through the end of four quarters following the transaction.
(2)Represents revenues attributable to dispositions for the four quarters preceding the disposition date.
Adjusted EBIT*For the three months ended March 31
20242023% change
Net income attributable to GE HealthCare$374$372—%
Add: Interest and other financial charges – net122136
Add: Non-operating benefit (income) costs(102)(115)
Less: Benefit (provision) for income taxes(124)(163)
Less: Net (income) loss attributable to noncontrolling interests(14)(11)
EBIT*$531$567(6)%
Add: Restructuring costs(1)4012
Add: Acquisition and disposition-related charges (benefits)(2)—1
Add: Spin-Off and separation costs(3)6058
Add: (Gain) loss on business and asset dispositions(4)——
Add: Amortization of acquisition-related intangible assets3131
Add: Investment revaluation (gain) loss(5)20(5)
Adjusted EBIT*$681$6643%
Net income margin8.0%7.9%10 bps
Adjusted EBIT margin*14.7%14.1%50 bps
(1)Consists of severance, facility closures, and other charges associated with restructuring programs.
(2)Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.
(3)Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs.
(4)Consists of gains and losses resulting from the sale of assets and investments.
(5)Primarily relates to valuation adjustments for equity investments.
Adjusted Net Income*For the three months ended March 31
20242023% change
Net income attributable to GE HealthCare$374$372—%
Add: Non-operating benefit (income) costs(102)(115)
Add: Restructuring costs(1)4012
Add: Acquisition and disposition-related charges (benefits)(2)—1
Add: Spin-Off and separation costs(3)6058
Add: (Gain) loss on business and asset dispositions(4)——
Add: Amortization of acquisition-related intangible assets3131
Add: Investment revaluation (gain) loss(5)20(5)
Add: Tax effect of reconciling items(9)4
Add: Certain tax adjustments(6)—30
Adjusted net income*$413$3886%
(1)Consists of severance, facility closures, and other charges associated with restructuring programs.
(2)Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.
(3)Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs.
(4)Consists of gains and losses resulting from the sale of assets and investments.
(5)Primarily relates to valuation adjustments for equity investments.
(6)Consists of certain income tax adjustments, including the accrual of a deferred tax liability on the prior period earnings of certain of the Company’s foreign subsidiaries for which the Company is no longer permanently reinvested and the impact of adjusting deferred tax assets and liabilities to stand-alone GE HealthCare tax rates.
Adjusted Earnings Per Share*For the three months ended March 31
(In dollars, except shares outstanding presented in millions)20242023$ change
Diluted earnings per share$0.81$0.41$0.40
Add: Deemed preferred stock dividend of redeemable noncontrolling interest—0.40
Add: Non-operating benefit (income) costs(0.22)(0.25)
Add: Restructuring costs(1)0.090.03
Add: Acquisition and disposition-related charges (benefits)(2)—0.00
Add: Spin-Off and separation costs(3)0.130.13
Add: (Gain) loss on business and asset dispositions(4)——
Add: Amortization of acquisition-related intangible assets0.070.07
Add: Investment revaluation (gain) loss(5)0.04(0.01)
Add: Tax effect of reconciling items(0.02)0.01
Add: Certain tax adjustments(6)—0.07
Adjusted earnings per share*$0.90$0.85$0.05
Diluted weighted-average shares outstanding459457
(1)Consists of severance, facility closures, and other charges associated with restructuring programs.
(2)Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.
(3)Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs.
(4)Consists of gains and losses resulting from the sale of assets and investments.
(5)Primarily relates to valuation adjustments for equity investments.
(6)Consists of certain income tax adjustments, including the accrual of a deferred tax liability on the prior period earnings of certain of the Company’s foreign subsidiaries for which the Company is no longer permanently reinvested and the impact of adjusting deferred tax assets and liabilities to stand-alone GE HealthCare tax rates.
Adjusted Tax Expense* and Adjusted ETR*For the three months ended March 31
2024 · 2023
Benefit (provision) for income taxes$(124)$(163)
Add: Tax effect of reconciling items(9)4
Add: Certain tax adjustments(1)—30
Adjusted tax expense*$(133)$(129)
Effective tax rate24.2%29.9%
Adjusted effective tax rate*23.7%24.4%
(1)Consists of certain income tax adjustments, including the accrual of a deferred tax liability on the prior period earnings of certain of the Company’s foreign subsidiaries for which the Company is no longer permanently reinvested and the impact of adjusting deferred tax assets and liabilities to stand-alone GE HealthCare tax rates.
Free Cash Flow*For the three months ended March 31
20242023% change
Cash from (used for) operating activities$419$468(11)%
Add: Additions to PP&E and internal-use software(145)(143)
Add: Dispositions of PP&E——
Free cash flow*$274$325(16)%
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.